Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (663)	5/21/2002 2:05:52 AM
From: Mike McFarland	Read Replies (2) \| Respond to of 675

Is The Independent generally reliable? The Indy comments on cash strapped biotech group Cenes Pharmaceuticals (London: CEN.L - news) (CEN.L), who in the nick of time has received approaches for information from five interested parties, after efforts by current management and shareholders to encourage a sale. The group has slashed costs by cutting its board members to five, suspending research and closing its US operations, but on a brighter note revealed promising data last week on one product for pain caused by a malfunctioning central nervous system, and may also have a product that could be used to treat schizophrenia.